Earnings Call · Q3 FY2022·2022-11-02

Q3 22EPS 0.00%·Rev n/aQ2 22EPS 0.00%·Rev n/aQ1 22EPS -20.00%·Rev n/aQ4 21EPS 0.00%·Rev n/a⚠ consensus missing

Matinas BioPharma Holdings, Inc. MTNB

Ankit Bhargava — Unknown - likely IR or Communications based on speaking first and introducing the call

Jerry Jabbour — Chief Executive Officer (CEO) - inferred from leading the call, providing updates, and answering strategic questions

Terry Matkovits — Chief Medical Officer (CMO) - inferred from discussing clinical data and medical details

Terry Ferguson — Chief Scientific Officer (CSO) - inferred from discussing scientific and clinical study design details

Keith Kucinski — Chief Financial Officer (CFO) - inferred from discussing financial results

+0.2%1d on move date+2.7% vs SPY3d−3.0%5d−12.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MTNB calls or request research access.

More MTNB calls Browse calls Request research access